Trial · NCT02755298
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference in 6 min walk distance | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Difference of Quality of Life (QoL) assessed by the physical subscale of the living with pulmonary hypertension questionnaire (MLHF) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Progressive maximal ramp cardiopulmonary exercise testing | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | cerebral and muscle tissue oxygenation | 5 weeks | At the end of both periods (AZA and Placebo) at rest and exercise |
| Secondary | daily activity | 5 weeks | actigraphy |
| Secondary | morphological and functional parameters of the heart | 5 weeks | measured by echocardiography |
| Secondary | New York Heart Association functional class | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Short-form medical outcome questionnaire (SF-36) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | N-terminal pro-brain natriuretic Peptide (NT-proBNP) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | mean nocturnal oxygen Saturation during ambulatory sleep studies | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | apnea/hypopnea index during ambulatory sleep studies | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Stroop test of cognitive performance | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Trail making test (test of cognitive Performance) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | 5 point test (test of cognitive Performance) | 5 weeks | At the end of both periods (AZA and Placebo) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02755298/registered